Has Petr Jarolim, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,139 in general payments to Petr Jarolim, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Petr Jarolim, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Petr Jarolim, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Petr Jarolim, MD

Clinical Pathology/Laboratory Medicine · Boston, MANPI 1689690588

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,000 of the $8,139 with a category attached, or 61.4%. Roche Diagnostics Corporation accounts for 86.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $7,034 and has fallen 87.4% since, to $884 in 2025.

$8,139in general payments, 2019–2025

Across 21 payments — averaging $387.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Roche Diagnostics Corporation$7K
Siemens Medical Solutions USA, Inc.$884
Abbott$193

What the payments were for

Consulting fees$5,00061%
Travel & lodging$1,86823%
Food & beverage$1,27116%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Roche Diagnostics Corporation	12	$7,062
Siemens Medical Solutions USA, Inc.	7	$884
Abbott	2	$193

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CD cobas Reagents$6,045
POC CoaguChek Meters, Strips and Accessories$348
CD cobas Analyzer Series$155
Dimension EXL with LM$140
POC cobas Accutrend Meters, Strips and Assessories$124

How this compares

$8,139 in reported general payments places this provider in the 75th percentile of 27 clinical pathology/laboratory medicine providers in Massachusetts.

See all clinical pathology/laboratory medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$374,791

Medicare patients

5,312

Services billed

20,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Boston

Christopher StowellBoston$55K
Matthew MeyersonBoston$22K
Stacy MelansonBoston$21K
Anders BergBoston$13K
John HigginsBoston$10K
Sacha UljonBoston$8K
Dongsheng XuBoston$6K
Ileana Lopez PlazaBoston$5K
Steven SloanBoston$4K
Agata SmogorzewskaBoston$2K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →